<--- Back to Details
First PageDocument Content
Medicine / Bureau of Narcotics and Dangerous Drugs / Drug Enforcement Administration / Federal Bureau of Narcotics / Pharmacy / Pharmacist / Compounding / Medical prescription / Hospital pharmacy / Pharmaceutical sciences / Health / Pharmacology
Date: 2014-09-05 11:14:58
Medicine
Bureau of Narcotics and Dangerous Drugs
Drug Enforcement Administration
Federal Bureau of Narcotics
Pharmacy
Pharmacist
Compounding
Medical prescription
Hospital pharmacy
Pharmaceutical sciences
Health
Pharmacology

July 2014 Newsletter.indd

Add to Reading List

Source URL: health.mo.gov

Download Document from Source Website

File Size: 377,71 KB

Share Document on Facebook

Similar Documents

JCAMECH Vol. 49, No. 1, June 2018, ppDOI: jcamechEffect of nano-structuration and compounding of YSZ APS TBCs with different thickness on coating performance in thermal shock

DocID: 1vbK0 - View Document

ALABAMA STATE BOARD OF PHARMACY NOTICE OF INTENDED ACTION RULE NUMBER: 680-XTITLE OF RULE: REOUIREMENTS FOR COMPOUNDING 680-X-2-.43

DocID: 1uhGB - View Document

Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry

DocID: 1tBOU - View Document

data sheet Compounding CS 122Y-14P Chopped Strand for PC & PPO

DocID: 1syCN - View Document

data sheet Compounding DS8800-11P Chopped Strand for high T Plastics

DocID: 1rQMk - View Document